Golden State Equity Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.76M | Buy |
20,248
+57
| +0.3% | +$10.6K | 0.7% | 25 |
|
|
2025
Q1 | $4.23M | Sell |
20,191
-363
| -2% | -$76.1K | 0.84% | 18 |
|
|
2024
Q4 | $3.65M | Buy |
20,554
+14,780
| +256% | +$2.63M | 0.7% | 26 |
|
|
2024
Q3 | $1.14M | Sell |
5,774
-10,804
| -65% | -$2.14M | 0.6% | 28 |
|
|
2024
Q2 | $2.84M | Buy |
+16,578
| New | +$2.84M | 0.59% | 33 |
|
|
2023
Q4 | $2.57M | Sell |
16,573
-254
| -2% | -$39.4K | 0.62% | 36 |
|
|
2023
Q3 | $2.51M | Sell |
16,827
-182
| -1% | -$27.1K | 0.7% | 34 |
|
|
2023
Q2 | $2.29M | Buy |
17,009
+5,617
| +49% | +$757K | 0.64% | 32 |
|
|
2023
Q1 | $1.82M | Buy |
+11,392
| New | +$1.82M | 0.98% | 29 |
|
|
2022
Q1 | $1.11M | Buy |
6,864
+1,024
| +18% | +$166K | 0.56% | 54 |
|
|
2021
Q4 | $791K | Sell |
5,840
-3,809
| -39% | -$516K | 0.4% | 62 |
|
|
2021
Q3 | $1.04M | Buy |
9,649
+4,549
| +89% | +$491K | 0.42% | 57 |
|
|
2021
Q2 | $574K | Buy |
+5,100
| New | +$574K | 0.22% | 111 |
|